Auro Laboratories Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 239365, "name": "Auro Labs.", "stock_name": "Auro Labs.", "full_name": "Auro Laboratories Ltd", "name_url": "stocks-analysis/auro-labs", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "279.40", "chg": 2.4, "chgp": "0.87%", "dir": 1, "prev_price": "277.00", "mcapval": "173.00 Cr", "mcap": "Micro Cap", "scripcode": 530233, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE292C01011", "curr_date": "Mar 25", "curr_time": "", "bse_nse_vol": "7.71 k", "exc_status": "Active", "traded_date": "Mar 25, 2026", "traded_date_str": "2026 03 25", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/auro-labs-239365-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Auro Laboratories Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/auro-laboratories-ltd-is-rated-hold-3917808", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AuroLaboratorie_mojoScore_3917808.png", "date": "2026-03-26 10:10:26", "description": "Auro Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 02 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing." }, { "title": "Auro Laboratories Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/auro-laboratories-ltd-is-rated-hold-3892075", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AuroLaboratorie_mojoScore_3892075.png", "date": "2026-03-15 10:10:23", "description": "Auro Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 02 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook." }, { "title": "Auro Laboratories Ltd Downgraded to Hold Amid Mixed Financial and Technical Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/auro-laboratories-ltd-downgraded-to-hold-amid-mixed-financial-and-technical-signals-3865866", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AuroLaboratorie_mojoScore_3865866.png", "date": "2026-03-03 08:10:22", "description": "Auro Laboratories Ltd has seen its investment rating downgraded from Buy to Hold as of 2 March 2026, reflecting a nuanced assessment across quality, valuation, financial trends, and technical indicators. Despite strong recent financial performance and impressive long-term returns, concerns over debt servicing ability and valuation metrics have tempered enthusiasm among analysts." }, { "title": "Auro Laboratories Ltd is Rated Buy", "link": "https://www.marketsmojo.com/news/stock-recommendation/auro-laboratories-ltd-is-rated-buy-3864114", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AuroLaboratorie_mojoScore_3864114.png", "date": "2026-03-02 10:10:36", "description": "Auro Laboratories Ltd is rated Buy by MarketsMOJO, with this rating last updated on 18 February 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 02 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing." }, { "title": "Auro Laboratories Ltd Gains 0.22%: 4 Key Factors Driving the Week’s Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/auro-laboratories-ltd-gains-022-4-key-factors-driving-the-weeks-momentum-3863176", "imagepath": "", "date": "2026-03-01 11:00:04", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>16 Feb:</strong> Stock opens at Rs.293.10, modest gain of 0.46%</p>\n <p><strong>18 Feb:</strong> New 52-week and all-time high intraday price of Rs.317 reached</p>\n <p><strong>18 Feb:</strong> Formation of Golden Cross signals potential bullish breakout</p>\n <p><strong>19 Feb:</strong> Upgraded to Buy rating by MarketsMOJO on strong financial and technical signals</p>\n <p><strong>20 Feb:</strong> Week closes at Rs.291.10, down 0.22% for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"s..." }, { "title": "Auro Laboratories Ltd Upgraded to Buy on Strong Financial and Technical Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/auro-laboratories-ltd-upgraded-to-buy-on-strong-financial-and-technical-signals-3846399", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AuroLaboratorie_mojoScore_3846399.png", "date": "2026-02-19 08:05:07", "description": "Auro Laboratories Ltd has been upgraded from a Hold to a Buy rating by MarketsMOJO, reflecting significant improvements across technical indicators, financial trends, valuation metrics, and overall quality. The pharmaceutical company’s recent quarterly results, robust price momentum, and consistent long-term returns have collectively driven this positive reassessment, signalling renewed investor confidence in its growth prospects." }, { "title": "Auro Laboratories Ltd Forms Golden Cross, Signalling Potential Bullish Breakout", "link": "https://www.marketsmojo.com/news/stocks-in-action/auro-laboratories-ltd-forms-golden-cross-signalling-potential-bullish-breakout-3846070", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AuroLaboratorie_goldencross_3846070.png", "date": "2026-02-18 18:00:12", "description": "Auro Laboratories Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has recently formed a Golden Cross—a significant technical indicator where the 50-day moving average (DMA) has crossed above the 200-DMA. This development signals a potential bullish breakout and a long-term momentum shift, suggesting renewed investor confidence and a possible trend reversal in the stock’s trajectory." }, { "title": "Auro Laboratories Ltd Hits New 52-Week High of Rs.317 on 18 Feb 2026", "link": "https://www.marketsmojo.com/news/stocks-in-action/auro-laboratories-ltd-hits-new-52-week-high-of-rs317-on-18-feb-2026-3845945", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AuroLaboratorie_priceRelatedfactors_3845945.png", "date": "2026-02-18 14:35:18", "description": "Auro Laboratories Ltd has reached a new 52-week and all-time high of Rs.317, reflecting a robust rally in the Pharmaceuticals & Biotechnology sector. This milestone underscores the stock’s strong momentum, outperforming its sector peers and the broader market over the past year." }, { "title": "Auro Laboratories Ltd Stock Hits All-Time High Amid Robust Performance", "link": "https://www.marketsmojo.com/news/stocks-in-action/auro-laboratories-ltd-stock-hits-all-time-high-amid-robust-performance-3845916", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AuroLaboratorie_priceRelatedfactors_3845916.png", "date": "2026-02-18 13:15:32", "description": "Auro Laboratories Ltd has reached a significant milestone by hitting an all-time high in its stock price, reflecting a sustained period of strong performance within the Pharmaceuticals & Biotechnology sector. The stock’s recent surge underscores the company’s resilience and market strength as it outpaces key benchmarks and trading averages." } ], "total": 155, "sid": "239365", "stock_news_url": "https://www.marketsmojo.com/news/auro-laboratories-239365" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "07-Feb-2026", "details": "Auro Laboratories Limited has submitted the clippings of Newspaper Publication of the Unaudited Financial Results of the Quarter and Nine Months ended December 31 2025.", "source": "BSE" }, { "caption": "Financial Results For The Quarter Ended December 31 2025", "datetime": "05-Feb-2026", "details": "Auro Laboratories Limited has submitted Financial Results for the quarter ended December 31 2025.", "source": "BSE" }, { "caption": "Board Meeting Outcome for Outcome Of The Board Meeting", "datetime": "05-Feb-2026", "details": "Auro Laboratories Limited has submitted the Financial Results for the Quarter Ended December 31 2025.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

16 Feb: Stock opens at Rs.293.10, modest gain of 0.46%

18 Feb: New 52-week and all-time high intraday price of Rs.317 reached

18 Feb: Formation of Golden Cross signals potential bullish breakout

19 Feb: Upgraded to Buy rating by MarketsMOJO on strong financial and technical signals

20 Feb: Week closes at Rs.291.10, down 0.22% for the week

Week Open

Read full news article

Auro Laboratories Ltd Upgraded to Buy on Strong Financial and Technical Signals

2026-02-19 08:05:07

Auro Laboratories Ltd has been upgraded from a Hold to a Buy rating by MarketsMOJO, reflecting significant improvements across technical indicators, financial trends, valuation metrics, and overall quality. The pharmaceutical company’s recent quarterly results, robust price momentum, and consistent long-term returns have collectively driven this positive reassessment, signalling renewed investor confidence in its growth prospects.

Read full news article

Auro Laboratories Ltd Forms Golden Cross, Signalling Potential Bullish Breakout

2026-02-18 18:00:12

Auro Laboratories Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has recently formed a Golden Cross—a significant technical indicator where the 50-day moving average (DMA) has crossed above the 200-DMA. This development signals a potential bullish breakout and a long-term momentum shift, suggesting renewed investor confidence and a possible trend reversal in the stock’s trajectory.

Read full news article

Auro Laboratories Ltd Hits New 52-Week High of Rs.317 on 18 Feb 2026

2026-02-18 14:35:18

Auro Laboratories Ltd has reached a new 52-week and all-time high of Rs.317, reflecting a robust rally in the Pharmaceuticals & Biotechnology sector. This milestone underscores the stock’s strong momentum, outperforming its sector peers and the broader market over the past year.

Read full news article

Auro Laboratories Ltd Stock Hits All-Time High Amid Robust Performance

2026-02-18 13:15:32

Auro Laboratories Ltd has reached a significant milestone by hitting an all-time high in its stock price, reflecting a sustained period of strong performance within the Pharmaceuticals & Biotechnology sector. The stock’s recent surge underscores the company’s resilience and market strength as it outpaces key benchmarks and trading averages.

Read full news article